Stock SUVENPHAR SUVEN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Suven Pharmaceuticals Limited Bombay S.E.

Equities

SUVENPHAR

INE03QK01018

Market Closed - Bombay S.E.
Other stock markets
 06:00:47 2024-05-17 EDT 		5-day change 1st Jan Change
642.4 INR -0.48% Intraday chart for Suven Pharmaceuticals Limited -0.50% -11.54%
03-27 Suven Pharmaceuticals Limited Announces Shifting of Registered Office CI
03-05 Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Suven Pharmaceuticals Limited Announces Shifting of Registered Office
CI
Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call
Indian shares set to rise on strong domestic growth, in-line US inflation data
RE
Suven Pharmaceuticals Limited agreed to acquire Cohance Lifesciences Limited for INR 81,340.421103 million
CI
US FDA Clears Suven Pharmaceuticals' API and Formulations Plants in Hyderabad, India
MT
Suven Pharmaceuticals' Consolidated Net Profit Declines in Fiscal Q3
MT
Transcript : Suven Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 05, 2024
Suven Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Suven Pharmaceuticals CFO Steps Down
MT
Suven Pharmaceuticals Limited Announces CFO Changes, Effective January 2, 2024
CI
Suven Pharmaceuticals Names CFO
MT
Suven Pharmaceuticals Limited Appoints Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju as Managing Director
CI
Suven Pharmaceuticals Limited Announces Board Appointments
CI
Suven Pharmaceuticals Limited Approves Interim Dividend for the Financial Year 2023-24
CI
Suven Pharmaceuticals Limited Proposes Interim Dividend for the Financial Year 2022-23
CI
Suven Pharmaceuticals Posts Gains in Fiscal Q2 Consolidated Profit
MT
Suven Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Transcript : Suven Pharmaceuticals Limited, Q2 2024 Earnings Call, Nov 09, 2023
Berhyanda Limited completed the acquisition of 0.001% stake in Suven Pharmaceuticals Limited for INR 1.3 million.
CI
Suven Pharmaceuticals Limited Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SUVENPHAR Stock
  4. SUVENPHAR Stock
  5. News Suven Pharmaceuticals Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW